The Novel Therapeutic Potential Of Bovine Alpha-Lactalbumin Made Lethal To Tumour Cells (Balmet) And Oleic Acid In Oral Squamous Cell Carcinoma (Oscc)

BackgroundSince the serendipitous discovery of bovine alpha-lactalbumin made lethal to tumour cells (BAMLET)/human alpha-lactalbumin made lethal to tumour cells there has been an increased interest in the ability of the two components, oleic acid and alpha-lactalbumin, to form anti-cancer complexes. Here we have investigated the in-vitro efficacy of the BAMLET complex in killing oral cancer (OC) cells, determined the active component of the complex and investigated possible biological mechanisms.Materials and methodsTwo OC cell lines (+/- p53 mutation) and one dysplastic cell line were used as a model of progressive oral carcinogenesis. We performed cell viability assays with increasing BAMLET concentrations to determine the cytotoxic potential of the complex. We further analysed the individual components to determine their respective cytotoxicities. siRNA knockdown of p53 was used to determine its functional role in mediating sensitivity to BAMLET. Cell death mechanisms were investigated by flow cytometry, confocal microscopy and the lactate dehydrogenase assay.ResultsOur results show that BAMLET is cytotoxic to the OC and dysplastic cell lines in a time and dose-dependent manner. The cytotoxic component was found to be oleic acid, which, can induce cytotoxicity even when not in complex. Our results indicate that the mechanism of cytotoxicity occurs through multiple simultaneous events including cell cycle arrest, autophagy like processes with a minor involvement of necrosis.ConclusionDeciphering the mechanism of cytotoxicity will aid treatment modalities for OC. This study highlights the potential of BAMLET as a novel therapeutic strategy in oral dysplastic and cancerous cells.